Description
The first edition of this book gained recognition as the definitive textbook of diabetes epidemiology. The second edition builds on this success, gathering recent information on international trends and data for diabetes mellitus. In particular, the book highlights the dramatic rise of Type 2 diabetes in children, adolescents and the elderly throughout the world. One new section features prevention and screening of both Type1 and Type 2 diabetes. Other new chapters cover the epidemiology of obesity and the impact of nutrition, and review available guidelines for better worldwide glycemic control. Future challenges, including the effects of antipsychotic treatment and HIV infection and therapy on diabetes, are also addressed. All chapters have been completely revised and updated, covering:
- definitions, classification and risk factors for diabetes
- new evidence for screening and prevention of Type 1 and Type 2 diabetes
- epidemiology of complications and associated risk factors
- economic aspects: the direct and indirect costs of diabetes.
The Epidemiology of Diabetes Mellitus fills the need for a current compendium of diabetes epidemiology in the tradition of the first monumental text of the late Kelly West. It is essential reading for general practitioners, diabetologists, clinical endocrinologists, cardiologists, epidemiologists, nurses, dieticians, and other diabetes care providers, as well as health care decision makers.
Chapter
3: Diagnosis and Classification
pp.:
33 – 39
4: Epidemiology of Metabolic Syndrome
pp.:
39 – 59
5: Obesity and Diabetes
pp.:
59 – 85
6: Methodology for Physical Activity Assessment
pp.:
85 – 99
7: Epidemiology of Nutrition and Diabetes Mellitus: Etiology and Environmental Factors
pp.:
99 – 115
8: Genetic Epidemiology of Type 2 Diabetes
pp.:
115 – 123
9: Epidemiologic Aspects of Type 2 Diabetes Mellitus in Europe
pp.:
123 – 139
10: The Burden of Diabetes and its Complications in the Middle East and Eastern Mediterranean Region
pp.:
139 – 149
11: Epidemiology of Diabetes in Africa
pp.:
149 – 161
12: Epidemiology of Diabetes Mellitus in Latin America
pp.:
161 – 175
13: Diabetes in the Caribbean . . . an Epidemiological Review!
pp.:
175 – 191
15: Epidemiology of Diabetes Mellitus in China
pp.:
199 – 207
16: Epidemiology of Diabetes in South East Asia
pp.:
207 – 235
17: The Epidemiology of Diabetes in Pacific Island Populations
pp.:
235 – 253
18: Epidemiology of Type 2 Diabetes in North America
pp.:
253 – 269
19: Non-Caucasian North American Populations: Native Americans
pp.:
269 – 283
20: Epidemiology of Type 2 Diabetes in Hispanic North Americans
pp.:
283 – 301
21: Non-Caucasian North American Populations: African Americans
pp.:
301 – 323
22: Epidemiology of Diabetes in Asian North Americans
pp.:
323 – 351
23: Epidemiology of Type 2 Diabetes in Children and Adolescents
pp.:
351 – 367
24: Global Epidemiology of Type 1 Diabetes
pp.:
367 – 383
25: Epidemiology of Childhood Diabetes Mellitus in Non-Caucasian Populations
pp.:
383 – 413
26: Genetic Epidemiology of Type 1 Diabetes Mellitus
pp.:
413 – 431
27: Recent Trends in Screening and Prevention of Type 1 Diabetes
pp.:
431 – 441
28: Non pharmacological Prevention of Type 2 Diabetes
pp.:
441 – 463
29: Pharmacological Prevention of Type 2 Diabetes
pp.:
463 – 477
30: The Epidemiology of Eye Diseases in Diabetes
pp.:
477 – 503
31: The Epidemiology of Diabetic Kidney Disease
pp.:
503 – 527
32: Epidemiology of Large-vessel Disease in Diabetes: Coronary Heart Disease and Stroke
pp.:
527 – 547
33: The Epidemiology of Peripheral Vascular Disease
pp.:
547 – 567
34: Epidemiology of Diabetic Neuropathy
pp.:
567 – 593
35: Epidemiology of Acute Complications: Diabetic Ketoacidosis, Hyperglycemic Hyperosmolar State and Hypoglycemia
pp.:
593 – 605
36: Mortality and Life Expectancy Associated with Diabetes
pp.:
605 – 631
37: Economic Costs
pp.:
631 – 655
38: Clinical Practice Guidelines: A Global Perspective
pp.:
655 – 669
39: Antipsychotic Therapies and Glucose Dysregulation in the Mental Illness Population
pp.:
669 – 685
40: Diabetes, Insulin Resistance and Glucose Metabolism in HIV Infection and its Treatment
pp.:
685 – 693